Primary Therapy of Waldenstro{\~A}{\OE}{\"E}† m's Macroglobulinemia (WM) with Weekly Bortezomib, Low-Dose Dexamethasone and Rituximab (BDR): A Phase II Study of the European Myeloma Network
Primary Therapy of Waldenstro{\~A}{\OE}{\"E}† m's Macroglobulinemia (WM) with Weekly Bortezomib, Low-Dose Dexamethasone and Rituximab (BDR): A Phase II Study of the European Myeloma Network
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2010
Συγγραφείς:
Dimopoulos, Meletios A García-Sanz, Ramón Gavriatopoulou, Maria Morel, Pierre Kyrtsonis, Marie-Christine Katodritou, Eirini Michalis, Eurydiki Kartasis, Zafiris Leleu, Xavier Palladini, Giovanni others
